(Q33938143)

English

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis (English)

1 reference

Europe PubMed Central

30 July 2017

Gram-negative bacteria

0 references

cystic fibrosis

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

Matthew E. Falagas

6

object named as

Matthew E Falagas

1 reference

Europe PubMed Central

30 July 2017

author name string

Sofia K Kasiakou

1

1 reference

Europe PubMed Central

30 July 2017

Argyris Michalopoulos

2

1 reference

Europe PubMed Central

30 July 2017

Elpidoforos S Soteriades

3

1 reference

Europe PubMed Central

30 July 2017

George Samonis

4

1 reference

Europe PubMed Central

30 July 2017

George J Sermaides

5

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

30 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

30 July 2017

49

1 reference

Europe PubMed Central

30 July 2017

8

1 reference

Europe PubMed Central

30 July 2017

3136-3146

1 reference

Europe PubMed Central

30 July 2017

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

APACHE II: a severity of disease classification system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Toxicity of Colistin in Cystic Fibrosis Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

5 July 2018

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

TOXICITY OF COLISTIN AND POLYMIXIN B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Colistin (coly-mycin) in resistant bacterial infections. A clinical appraisal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Colistimethate toxicity. Report of a fatal case in a previously healthy child

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

Reliability of a measure of severity of illness: acute physiology of chronic health evaluation--II

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196256

29 October 2018

[Clinical use of colimycin F otic solution]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute renal failure due to overdosage of colistin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials of colistin. Effect of the oral administration of the colistin on the intestinal bacterial flora

1 reference

https://pubmed.ncbi.nlm.nih.gov/16048915

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.8.3136-3146.2005

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33938143&oldid=1536137143"